Sophie J Edwards1, Benoit Smeuninx1, James Mckendry1,2, Yusuke Nishimura1, Dan Luo1, Ryan N Marshall1, Molly Perkins1,3, Jill Ramsay1, Sophie Joanisse1,2, Andrew Philp4,5, Leigh Breen1,6. 1. School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom. 2. Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada. 3. School of Sport and Health Sciences, University of Exeter, Exeter, United Kingdom. 4. Garvan Institute of Medical Research, Sydney, New South Wales, Australia. 5. St Vincents Medical School, UNSW Medicine, UNSW Sydney, Sydney, New South Wales, Australia. 6. Medical Research Council-Arthritis Research UK Centre for Musculoskeletal Ageing Research, University of Birmingham, Birmingham, United Kingdom.
Abstract
BACKGROUND: Unavoidable periods of disuse lead to muscle atrophy and functional decline. Preventing such declines can reduce the risk of re-injury and improve recovery of normal physiological functioning. OBJECTIVES: We aimed to determine the effectiveness of high-dose leucine supplementation on muscle morphology and strength during 7 d of unilateral lower-limb immobilization, and the role of myofibrillar (MyoPS) and mitochondrial (MitoPS) protein synthesis in disuse atrophy. METHODS:Sixteen healthy males (mean ±SEM age: 23 ± 1 y) underwent 7 d of unilateral lower-limb immobilization, with thrice-daily leucine (LEU; n = 8) or placebo (PLA; n = 8) supplementation (15 g/d). Before and after immobilization, muscle strength and compartmental tissue composition were assessed. A primed continuous infusion of l-[ring-13C6]-phenylalanine with serial muscle biopsies was used to determine postabsorptive and postprandial (20 g milk protein) MyoPS and MitoPS, fiber morphology, markers of protein turnover, and mitochondrial function between the control leg (CTL) and the immobilized leg (IMB). RESULTS:Leg fat-free mass was reduced in IMB (mean ±SEM: -3.6% ± 0.5%; P = 0.030) but not CTL with no difference between supplementation groups. Isometric knee extensor strength declined to a greater extent in IMB (-27.9% ± 4.4%) than in CTL (-14.3% ± 4.4%; P = 0.043) with no difference between groups. In response to 20 g milk protein, postprandial MyoPS rates were significantly lower in IMB than in CTL (-22% ± 4%; P < 0.01) in both LEU and PLA. Postabsorptive MyoPS rates did not differ between legs or groups. Postabsorptive MitoPS rates were significantly lower in IMB than in CTL (-14% ± 5%; P < 0.01) and postprandial MitoPS rates significantly declined in response to 20 g milk protein ingestion (CTL: -10% ± 8%; IMB: -15% ± 10%; P = 0.039), with no differences between legs or groups. There were no significant differences in measures of mitochondrial respiration between legs, but peroxisome proliferator-activated receptor γ coactivator 1-α and oxidative phosphorylation complex II and III were significantly lower in IMB than in CTL (P < 0.05), with no differences between groups. CONCLUSIONS:High-dose leucine supplementation (15 g/d) does not appear to attenuate any functional declines associated with 7 d of limb immobilization in young, healthy males.This trial was registered at clinicaltrials.gov as NCT03762278.
RCT Entities:
BACKGROUND: Unavoidable periods of disuse lead to muscle atrophy and functional decline. Preventing such declines can reduce the risk of re-injury and improve recovery of normal physiological functioning. OBJECTIVES: We aimed to determine the effectiveness of high-dose leucine supplementation on muscle morphology and strength during 7 d of unilateral lower-limb immobilization, and the role of myofibrillar (MyoPS) and mitochondrial (MitoPS) protein synthesis in disuse atrophy. METHODS: Sixteen healthy males (mean ± SEM age: 23 ± 1 y) underwent 7 d of unilateral lower-limb immobilization, with thrice-daily leucine (LEU; n = 8) or placebo (PLA; n = 8) supplementation (15 g/d). Before and after immobilization, muscle strength and compartmental tissue composition were assessed. A primed continuous infusion of l-[ring-13C6]-phenylalanine with serial muscle biopsies was used to determine postabsorptive and postprandial (20 g milk protein) MyoPS and MitoPS, fiber morphology, markers of protein turnover, and mitochondrial function between the control leg (CTL) and the immobilized leg (IMB). RESULTS: Leg fat-free mass was reduced in IMB (mean ± SEM: -3.6% ± 0.5%; P = 0.030) but not CTL with no difference between supplementation groups. Isometric knee extensor strength declined to a greater extent in IMB (-27.9% ± 4.4%) than in CTL (-14.3% ± 4.4%; P = 0.043) with no difference between groups. In response to 20 g milk protein, postprandial MyoPS rates were significantly lower in IMB than in CTL (-22% ± 4%; P < 0.01) in both LEU and PLA. Postabsorptive MyoPS rates did not differ between legs or groups. Postabsorptive MitoPS rates were significantly lower in IMB than in CTL (-14% ± 5%; P < 0.01) and postprandial MitoPS rates significantly declined in response to 20 g milk protein ingestion (CTL: -10% ± 8%; IMB: -15% ± 10%; P = 0.039), with no differences between legs or groups. There were no significant differences in measures of mitochondrial respiration between legs, but peroxisome proliferator-activated receptor γ coactivator 1-α and oxidative phosphorylation complex II and III were significantly lower in IMB than in CTL (P < 0.05), with no differences between groups. CONCLUSIONS: High-dose leucine supplementation (15 g/d) does not appear to attenuate any functional declines associated with 7 d of limb immobilization in young, healthy males.This trial was registered at clinicaltrials.gov as NCT03762278.
Authors: Sophie J Edwards; Brandon J Shad; Ryan N Marshall; Paul T Morgan; Gareth A Wallis; Leigh Breen Journal: J Appl Physiol (1985) Date: 2021-11-04
Authors: Tom S O Jameson; Sean P Kilroe; Jonathan Fulford; Doaa R Abdelrahman; Andrew J Murton; Marlou L Dirks; Francis B Stephens; Benjamin T Wall Journal: Am J Physiol Endocrinol Metab Date: 2021-10-11 Impact factor: 4.310
Authors: Jamie-Lee M Thompson; Daniel W D West; Thomas M Doering; Boris P Budiono; Sarah J Lessard; Lauren G Koch; Steven L Britton; Nuala M Byrne; Matthew A Brown; Kevin J Ashton; Vernon G Coffey Journal: PLoS One Date: 2022-01-13 Impact factor: 3.240
Authors: Ryan N Marshall; Benoit Smeuninx; Alex P Seabright; Paul T Morgan; Philip J Atherton; Andrew Philp; Leigh Breen Journal: Physiol Rep Date: 2022-07
Authors: Emily E Howard; Lee M Margolis; Maya A Fussell; Clifford G Rios; Eric M Meisterling; Christopher J Lena; Stefan M Pasiakos; Nancy R Rodriguez Journal: Nutrients Date: 2022-01-27 Impact factor: 5.717